BioNTech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 76.25% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
42.8%	AT Impf GmbH	102,489,101	US$12.5b	-1.5%	no data
17.2%	Ugur Sahin	41,295,728	US$5.0b	0%	no data
3.47%	Baillie Gifford & Co.	8,308,071	US$1.0b	0.38%	0.4%
2.49%	FMR LLC	5,979,545	US$727.8m	770%	0.04%
1.88%	PRIMECAP Management Company	4,516,518	US$549.8m	-5.7%	0.36%
1.82%	Flossbach & Von Storch Vermoegensmanagement AG	4,359,607	US$530.6m	-0.45%	1.24%
0.86%	BlackRock, Inc.	2,071,934	US$252.2m	9.31%	no data
0.81%	Capital Research and Management Company	1,951,606	US$237.5m	-0.09%	0.01%
0.75%	Temasek Holdings (Private) Limited	1,807,232	US$220.0m	0%	0.17%
0.5%	Salvia GmbH	1,193,651	US$145.3m	0%	no data
0.39%	Candriam, Société En Commandite Par Actions	927,164	US$112.9m	60.1%	0.29%
0.38%	Ozlem Tureci	913,247	US$111.2m	0%	no data
0.34%	Sean Marett	815,263	US$99.2m	0%	no data
0.31%	Sierk Poetting	754,784	US$91.9m	0%	no data
0.27%	Morgan Stanley, Investment Banking and Brokerage Investments	653,618	US$79.6m	-41.2%	0.01%
0.27%	Altrinsic Global Advisors, LLC	652,706	US$79.4m	-3.48%	2.07%
0.26%	Balyasny Asset Management L.P.	620,466	US$75.5m	36.1%	0.18%
0.21%	Fred Alger Management, LLC	500,844	US$61.0m	0%	0.24%
0.2%	Acatis Anlageberatung fur Investmentfonds GmbH	486,632	US$59.2m	0%	3.65%
0.2%	Deka Investment GmbH	481,397	US$58.6m	12.6%	0.05%
0.19%	First Trust Advisors LP	451,192	US$54.9m	10.3%	0.04%
0.17%	Quinn Opportunity Partners LLC	404,500	US$49.2m	-40.8%	3.99%
0.17%	Voloridge Investment Management, LLC	400,306	US$48.7m	48.3%	0.16%
0.16%	Point72 Asset Management, L.P.	389,238	US$47.4m	-15.7%	0.11%
0.16%	Amundi Asset Management SAS	372,756	US$45.4m	33.6%	0.01%